You are using an outdated browser. Please upgrade your browser to improve your experience.

Our Focus

Chiasma is a biopharmaceutical company focused on improving the lives of patients who face challenges associated with existing treatments for their rare and serious chronic diseases. Employing its Transient Permeability Enhancer (TPE®) technology platform, Chiasma seeks to select, develop and ultimately commercialize oral medications that are currently only available as injections.